The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.
Morning Overview on MSN
Europe becomes first to authorize Moderna’s combined flu-COVID mRNA shot
Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...
A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...
The U.S. Food and Drug Administration plans to change how COVID vaccines and other shots are approved and administered. The memo, which was written by FDA chief medical and scientific officer Vinay ...
Morning Overview on MSN
EU clears Moderna’s combined flu-COVID shot for older adults
Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the ...
New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results